Concepedia

Rituximab as Treatment for Refractory Kidney Transplant Rejection

Yolanda T. Becker, Bryan N. Becker, John D. Pirsch, Hans W. Sollinger

American Journal of Transplantation · 2004 · 308 citations · 22 references

DOI

Concepts

References

22

The Banff 97 working classification of renal allograft pathology

Lorraine C. Racusen, Kim Solez, Robert B. Colvin et al. · Kidney International · 1999 · 3.1K citations

, , +17

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

ME Reff, K Carner, KS Chambers et al. · Blood · 1994 · 1.9K citations · Full text

, , +14

Humoral Immunity Due to Long-Lived Plasma Cells

Mark K. Slifka, Rustom Antia, Jason K. Whitmire et al. · Immunity · 1998 · 1.3K citations · Full text

, , +14

Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection

Lorraine C. Racusen, Robert B. Colvin, Kim Solez et al. · American Journal of Transplantation · 2003 · 1.1K citations · Full text

, , +12

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

B. Coiffier, Corinne Haïoun, Nicolas Ketterer et al. · PubMed · 1998 · 898 citations

, , +15